Proteomics based identification of KDM5 histone demethylases associated with cardiovascular disease
Marika Mokou(National and Kapodistrian University of Athens), Antonia Vlahou(Academy of Athens)
Cited by 46
Related Papers
Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
|Science Translational Medicine|2010|335
Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study
|Clinical Cancer Research|2016|104
Microhematuria assessment an IBCN consensus—Based upon a critical review of current guidelines
|Urologic Oncology Seminars and Original Investigations|2016|33
Urinary peptide panel for prognostic assessment of bladder cancer relapse
|Scientific Reports|2019|23